Acute angle-closure glaucoma (AACG) represents a true ophthalmological emergency defined by the sudden, complete or near-complete mechanical obstruction of the trabecular meshwork by the peripheral iris1,2. This physical blockage arrests the normal drainage of aqueous humor from the posterior chamber into the anterior chamber angle, driving intraocular pressure (IOP) to critically high levels, often exceeding 50 to 60 mmHg. Without prompt medical decompression and definitive surgical intervention, the resulting ischemia leads to irreversible damage to the retinal ganglion cells, optic nerve head cupping, and profound, permanent vision loss2,5.

1. Etiology & Risk Factors

  • Anatomical Predisposition: Inherently shallow anterior chambers, short axial length (hyperopia/farsightedness), thick crystalline lenses, and an anterior lens position predispose patients to narrow angles3,4.
  • Demographic Factors: Advanced age (due to physiological lens growth), female biological sex (at a ratio of approximately 3:1 to 4:1), and Asian ethnicity are major demographic risk factors3.
  • Pharmacological Triggers (Mydriatics & Sympathomimetics): Topical or systemic agents that induce pupillary dilation—such as tropicamide, atropine, phenylephrine, and systemic decongestants containing pseudoephedrine—bunch the iris tissue against the angle, triggering closure in susceptible eyes3,4,7.
  • Pharmacological Triggers (Anticholinergics & Antidepressants): Tricyclic antidepressants, selective serotonin reuptake inhibitors, and anti-anxiety medications can precipitate pupillary block or produce ciliary body swelling through anticholinergic or idiosyncratic mechanisms3,4,5.
  • Infectious & Inflammatory Conditions: Rare viral or infectious entities, such as dengue fever or severe viral respiratory illnesses complicated by immune-mediated uveitis or fluid shifts, have been documented to induce secondary angle closure6,7.

2. Pathophysiology

Aqueous humor is continuously secreted by the ciliary body into the posterior chamber, flowing forward through the pupil into the anterior chamber before exiting through the trabecular meshwork into Schlemm's canal. In individuals with anatomically narrow angles, physiological pupillary dilation places the iris-lens diaphragm in direct contact, creating a relative pupillary block that prevents normal anterior fluid flow2,3. As fluid accumulates behind the iris, the peripheral iris bows forward into a convex configuration (iris bombe), sealing off the iridocorneal angle. The sudden cessation of aqueous outflow causes an exponential surge in intraocular pressure. This acute pressure spike induces corneal endothelial pump failure and edema, ischemia of the iris sphincter muscle resulting in a fixed mid-dilated pupil, and mechanical compression of the optic nerve axons and retinal microvasculature, threatening acute ischemic retinopathy2,4.

Acute angle-closure glaucoma — Pathophysiological Cascade & Clinical Flowchart 1 Trigger / Primary Insult Anatomically narrow anterior chamber angle undergoes pupillary block 2 Cellular / Pathophysiological Cascade Iris apposition to the trabecular meshwork completely blocks aqueous outflow 3 Target Organ / Structural Change Intraocular pressure spikes rapidly from 15 mmHg to over 50 mmHg 4 Hallmark Clinical & Diagnostic Manifestation Severe ocular pain, corneal epithelial edema, halos around lights, and a fixed mid-dilated pupil 5 Complications if Untreated & Therapeutic Target Permanent optic nerve damage prevented via emergency IOP-lowering agents and laser iridotomy

3. Clinical Presentation & Classic Clinical Signs

  • History & Cardinal Symptoms: Patients classically present with a sudden onset of severe, deep, unilateral ocular or peri-orbital pain radiating to the forehead and temple, accompanied by visceral symptoms of nausea, vomiting, and profound malaise secondary to trigeminal nerve stimulation2. Visual disturbances include acute blurred vision accompanied by classic colored, rainbow-like halos around white light sources due to corneal epithelial edema2.
  • Physical Examination & Named Clinical Signs: Examination reveals a markedly reduced visual acuity, a "rock-hard" globe on digital palpation, and a characteristic red eye driven by a deep ciliary flush (circumcorneal injection)2. The cornea appears hazy and steamy due to epithelial edema. The pupil is characteristically fixed, mid-dilated (approximately 4 to 6 mm), and unreactive to light. Gonioscopy of the contralateral asymptomatic eye typically confirms a narrow, occludable angle with appositional contact between the iris and trabecular meshwork2,3.

4. Diagnostic Workup & Interpretation (Laboratory, Imaging & ECG/Pathology)

Diagnostic Modality / Test Expected Clinical & Radiological / Laboratory Finding
Gold-Standard InvestigationGoldmann Applanation Tonometry demonstrating markedly elevated intraocular pressure, typically ranging from 40 to 60 mmHg (normal baseline: 10–21 mmHg)1,2.
Laboratory PanelBasic metabolic panel and serum osmolality if intravenous osmotic agents (such as mannitol) are contemplated, ensuring stable renal function.
Imaging / Radiology (X-ray, US, CT, MRI)Ultrasound biomicroscopy (UBM) or anterior segment optical coherence tomography (AS-OCT) revealing a narrow iridocorneal angle, iris bombe configuration, and shallow anterior chamber depth.
ECG / Histopathology / ProceduralSlit-lamp biomicroscopy combined with gonioscopy confirming complete closure of the drainage angle without visible trabecular structures across 360 degrees.

5. Staging, Classification & Clinical Scoring Systems

Criterion / Stage / Score Component Clinical Threshold, Points & Management Implication
Primary Angle-Closure Suspect (PACS)Posterior trabecular meshwork not visible for at least 180 degrees on gonioscopy; normal IOP and no peripheral anterior synechiae. Prophylactic LPI may be considered.
Primary Angle-Closure (PAC)Occludable angle accompanied by features of trabecular obstruction, such as peripheral anterior synechiae (PAS), elevated IOP, or iris whirling, without glaucomatous optic neuropathy.
Acute Primary Angle-Closure (APAC)Symptomatic acute attack characterized by acute IOP spike, corneal edema, pain, and systemic symptoms requiring immediate emergency decompression and definitive laser therapy.
Absolute Glaucoma StageEnd-stage untreated disease presenting with a completely blind, stone-hard, pain-free or painful eye showing total optic nerve atrophy and zero light perception.

6. Differential Diagnosis

Differential Condition Distinguishing Clinical, Biochemical & Imaging Features
Acute Anterior Uveitis (Iritis)Presents with a red eye and pain, but IOP is typically normal or low due to ciliary body inflammation, accompanied by anterior chamber cells, flare, and a constricted (miotic) pupil rather than a mid-dilated pupil.
Neovascular GlaucomaSecondary angle closure caused by fibrovascular membranes across the angle; gonioscopy reveals visible iris neovascularization (rubeosis iridis), typically in the setting of proliferative diabetic retinopathy or central retinal vein occlusion.
Corneal Abrasion or UlcerAssociated with severe eye pain and photophobia, but fluorescein staining reveals epithelial defect, and IOP is normal without mid-dilated fixation or halos.
Migraine / Cluster HeadacheCan present with severe unilateral head and periorbital pain accompanied by nausea and vomiting, but visual changes lack rainbow halos, the eye is white, and intraocular pressure remains entirely normal.

7. Management & Treatment Protocol

  • Initial Stabilization & Resuscitation: Place the patient immediately in a supine position to encourage posterior gravitational shift of the lens-iris diaphragm, reducing pupillary block while preparing emergency pharmacological therapy.
  • First-Line Medical / Pharmacological Therapy (with exact adult dosing): Administer IV Acetazolamide 500 mg stat (unless contraindicated by severe sulfa allergy or renal failure) combined with topical aqueous suppressants (Timolol maleate 0.5% one drop twice daily or Apraclonidine 0.5% / Brimonidine 0.2%). Osmotic agents such as IV Mannitol (1–2 g/kg of a 20% solution over 45 minutes) should be given if IOP remains refractory above 40 mmHg. Administer Topical Pilocarpine 2% to 4% (one drop every 15 minutes for two doses, then twice hourly) *only* after initial medical therapy has successfully lowered the IOP below 40 mmHg, as severe ischemic paralysis renders the sphincter unresponsive at higher pressures1,6.
  • Surgical / Interventional Indications: Once corneal edema clears sufficiently to permit visualization, perform definitive bilateral Laser Peripheral Iridotomy (LPI) using an Nd:YAG laser to create an alternative channel for aqueous humor flow between the posterior and anterior chambers, permanently resolving pupillary block and protecting the fellow eye1,6.

8. Complications & Prognosis

  • Acute and Chronic Complications: Persistent elevated intraocular pressure can result in permanent optic nerve excavation, glaucomatous visual field loss, formation of permanent peripheral anterior synechiae (PAS), glaucomatocfleckien (subcapsular lens opacities resulting from lens epithelial cell necrosis), and central retinal artery occlusion1,3.
  • Prognosis: Prognosis is exceptionally favorable if diagnosis and therapeutic intervention occur within hours of symptom onset. Delayed presentation beyond 24 to 48 hours carries a high risk of permanent, severe vision loss and chronic secondary glaucoma requiring surgical trabeculectomy or tube shunt insertion2,5.